ArticleOpen forum infectious diseases2018

Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir.

Jomy M George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.